Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire-Reference-Cited by-同舟云学术

Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire

Published:2020-12-15 Issue:12 Volume:202 Page:1689-1697
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Swigris Jeffrey J.¹,Andrae David A.²,Churney Tara³,Johnson Nathan²,Scholand Mary Beth⁴,White Eric S.⁵,Matsui Alison⁶,Raimundo Karina⁶,Evans Christopher J.²

Affiliation:

1. Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado

2. Endpoint Outcomes, Boston, Massachusetts

3. Department of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, Colorado

4. Division of Pulmonary Medicine, University of Utah, Salt Lake City, Utah

5. Interstitial Lung Disease Program, University of Michigan, Ann Arbor, Michigan; and

6. Genentech, South San Francisco, California

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference35 articles.

1. Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011

3. A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis

4. Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003

5. Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating the assessment of quality of life in care and research in pulmonary fibrosis;Current Opinion in Pulmonary Medicine;2024-07-01

2. Interventions to Improve Quality of Life and Knowledge in Hypersensitivity Pneumonitis;CHEST Pulmonary;2024-07

3. Impact of Pirfenidone on Patient-Reported Outcomes in Patients With Idiopathic Pulmonary Fibrosis From the Pulmonary Fibrosis Foundation Patient Registry;CHEST Pulmonary;2024-07

4. Dyspnea and Quality of Life Improvements with Management of Comorbid Obstructive Sleep Apnea in Chronic Lung Disease;Sleep Medicine Clinics;2024-06

5. A first look at the reliability, validity and responsiveness of L-PF-35 dyspnea domain scores in fibrotic hypersensitivity pneumonitis;BMC Pulmonary Medicine;2024-04-19